Submit Your Feeds

Business News • PR NewsWire • Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate
Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

PARIS and THE WOODLANDS, Texas, Oct. 22, 2014 /PRNewswire/ -- Ipsen (Euronext: IPN; ADR: IPSEY) and Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that they have entered into an exclusive licensing agreement for Ipsen to commercialize telotristat etiprate outside...

View More : http://www.prnewswire.com/news-releases/lexicon-and-ipsen-enter-into-ex-north-americajapan-licensing-and-commercializati...
Releted News by prnewswire
Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate
Switzerland is the Best Place for Expat Life
Mina Group CFO Named 'Revolutionary CFO of the Year' - 7th Annual MENA CFO Awards
Home Sitemap Contact Us
© businessNewsNewsNews.com